-
The FDA has approved the first oral medication for the treatment of patients with relapsing forms of multiple sclerosis.
-
The introduction of acellular pertussis vaccines represented an important advance in public health, but developing a vaccine is not synonymous with protecting a population.
-
Three 8-oz glasses of fat-free milk per day provided significant relief to patients with functional constipation.
-
-
Microbicide research is moving forward with two new developments: the Food and Drug Administration (FDA) has granted Fast Track approval designation for 1% tenofovir gel, which will facilitate the development and expedite the review of the drug.
-
Your next patient tells you she would like to use oral contraceptives (OCs) for birth control, but she says a family member told her using pills would affect her long-term fertility. What information do you provide her regarding OCs?
-
In a year when belt-tightening seemed to be a national pastime, about 35% of participants in the Contraceptive Technology Update Salary Survey reported a 1-3% uptick in salary, with 43% seeing no change in pay levels.
-
Add Beyaz and Lo Loestrin Fe to the list of birth control choices for U.S. women. Both oral contraceptives (OCs) received Food and Drug Administration (FDA) approval in late 2010.
-
-
The end of September, marking six months after President Obama signed into law the Patient Protection and Affordable Care Act, was the effective date for numerous provisions intended to expand patients' rights and coverage under private insurance.